Current therapies for Parkinson’s patients facing motor fluctuations are far from ideal—infusion pumps that irritate the skin and limit quality of life. Serina Therapeutics is taking a bold step forward by reimagining apomorphine delivery through its unique polymer platform. The result? A shot at delivering consistent, long-lasting relief with fewer side effects.
This innovation could dramatically improve outcomes for thousands of late-stage Parkinson’s patients.
#InnovationAndLeadership #Biotech #ParkinsonsResearch #HealthcareInnovation #DrugDevelopment #MedicalBreakthroughs #SerinaTherapeutics #FlagshipPioneering #Leadership #YouTubeShorts
